Actively Recruiting
AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication
Led by National University of Singapore · Updated on 2024-10-03
450
Participants Needed
2
Research Sites
87 weeks
Total Duration
On this page
Sponsors
N
National University of Singapore
Lead Sponsor
N
National University Polyclinics, Singapore
Collaborating Sponsor
AI-Summary
What this Trial Is About
Investigators hypothesize that the use of a human coach-supported digital/AI personal health assistant (app) will improve adherence to cholesterol-lowering medications (statins with or without ezetimibe) among patients with hyperlipidaemia and suboptimal LDL-C control, when compared to standard care.
CONDITIONS
Official Title
AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Between 21 to 84 years old
- Prescribed statins with or without ezetimibe for hyperlipidaemia
- Medication non-adherence with a score greater than 1 on the Extent to Non-adherence sub-scale of the DOSE Non-Adherence Measure
- Singapore residents (citizens, permanent residents, or long-term pass holders)
- Own a smartphone or tablet with Android or iOS operating systems
- Have internet access on their mobile devices
You will not qualify if you...
- Does not read or understand English
- Currently using smartphone medication adherence apps that include statins
- Taking PCSK9 inhibitors along with statins and/or ezetimibe
- Participating in another study using medications affecting lipid levels
- Severe kidney disease (chronic kidney disease stage 4 or higher)
- Severe liver disease (Child-Pugh Class C)
- Existing muscle-related complaints or diagnoses that may affect adverse event reporting
- Uncorrected or poorly-controlled thyroid conditions
- Documented psychiatric illness or unable to give informed consent
- Currently pregnant, breastfeeding, or planning pregnancy during the study
- Life expectancy less than 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
National Healthcare Group Polyclinics
Singapore, Singapore, 138543
Actively Recruiting
2
National University Polyclinics
Singapore, Singapore, 609606
Actively Recruiting
Research Team
D
Doreen Su-Yin Tan, Pharm.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here